Zomedica Corp.
ZOM was delisted on the 4th of March, 2025.
102 hedge funds and large institutions have $157M invested in Zomedica Corp. in 2021 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 7 closing their positions.
1,314% more capital invested
Capital invested by funds: $11.1M → $157M (+$146M)
914% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 7
217% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 6
168% more funds holding
Funds holding: 38 → 102 (+64)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$35M |
| 2 |
BlackRock
New York
|
+$14.2M |
| 3 |
State Street
Boston,
Massachusetts
|
+$8.78M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.1M |
| 5 |
BBHC
Brown Brothers Harriman & Co
New York
|
+$3.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WG
Winton Group
London,
United Kingdom
|
-$321K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$279K |
| 3 |
Morgan Stanley
New York
|
-$146K |
| 4 |
IWC
Integrated Wealth Concepts
Waltham,
Massachusetts
|
-$19K |
| 5 |
Jane Street
New York
|
-$17K |
ZOM Hedge Fund Activity: Q1 2021 in Review
102 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q1 2021, worth a combined $157M — up 1,314% from $11.1M a quarter earlier.
Buyers outnumbered sellers: 71 funds opened new ZOM positions and 7 closed out — a net gain of 64 holders — while 19 added to existing stakes and 6 trimmed.
The largest buyer was Vanguard Group, adding an estimated $35M. The largest seller was Winton Group, exiting entirely with an estimated $321K sold.
- 102 institutional investors held Zomedica Corp. (ZOM) as of Q1 2021, up from 38 in Q4 2020.
- Funds reported $157M of Zomedica Corp. stock for Q1 2021, up 1,314% quarter-over-quarter.
- 71 funds opened new Zomedica Corp. positions in Q1 2021 and 7 closed out, a net change of +64 holders.
- The largest Zomedica Corp. buyer in Q1 2021 was Vanguard Group, an estimated $35M added.
- The largest Zomedica Corp. seller in Q1 2021 was Winton Group, an estimated $321K sold.
Based on aggregated 13F filings for Q1 2021.